With a distinguished career advancing blood cancer research and patient care, Byrd will join the Division of Malignant Hematology and Medical Oncology and lead all cancer-related research at UPMC and the University of Pittsburgh, beginning November 2025.
Renowned Hematologic Oncologist Dr. John C. Byrd Named Director of UPMC Hillman Cancer Center
